TMX Newsfile Healthcare and Hospitals News Releases

MyndTec Inc. Makes Voluntary Assignment in Bankruptcy Under the Bankruptcy and Insolvency Act (Canada)

Fri, 24 Apr 2026 16:41:00 -0400

Mississauga, Ontario--(Newsfile Corp. - April 24, 2026) - Further to its press release dated April 8, 2026, MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company") announced today that, having been unable to secure the additional financing required to continue operations, it has made a voluntary assignment in bankruptcy for the general benefit of its creditors pursuant to section 49 of the Bankruptcy and Insolvency Act (Canada) (the "BIA").After careful consideration of available alternatives and...

HealthPlus Staffing Signs Dr. Alex Ferro as Franchisee, Introducing a Physician-Led Model Set to Redefine Healthcare Recruitment

Thu, 23 Apr 2026 19:32:00 -0400

Wellington, Florida--(Newsfile Corp. - April 23, 2026) - HealthPlus Staffing, one of the nation's fastest-growing healthcare staffing firms and a 2025 Inc. Regionals honoree, today announced the addition of Dr. Alex Ferro, a board-certified OBGYN with more than 20 years of clinical experience, as a franchisee leading Women's Health recruitment across the state of Florida.Left to right: Dr. Alex Ferro, Leo Ortiz, Ryan Kuhlman, Nader AtouiTo view an enhanced version of this graphic, please...

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series

Thu, 23 Apr 2026 07:00:00 -0400

King of Prussia, Pennsylvania--(Newsfile Corp. - April 23, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will provide an overview of the Company's INTASYL siRNA platform and discuss recent clinical progress and priorities, followed by a live...

Trenchant Technologies Capital Corp. Completes Unwinding of Previous Limitless Quantum Acquisition and Corporate Updates

Wed, 22 Apr 2026 08:30:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - Trenchant Technologies Capital Corp. (CSE: AITT) (OTCQB: AITTF) ("Trenchant" or the "Company") announces that it has completed the unwinding of the Company's acquisition of Limitless Quantum Computing Solutions Inc. ("Limitless Quantum") (collectively, the "Unwinding Transaction"), as previously announced on April 8, 2026.The Company has effectively cancelled the 10,000,000 common shares of the Company (the "Trenchant Shares") and...

Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant

Wed, 22 Apr 2026 08:00:00 -0400

White Bear Lake, Minnesota--(Newsfile Corp. - April 22, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that all 56 patients implanted and enrolled in its pivotal clinical trial evaluating the fully implanted Acclaim® cochlear implant have been through their "Activation Visits," when a patient's device is initially turned on for the first time. "The conclusion of our trial...

Adia Nutrition, Inc. Looking to Acquire Larger Property to Expand Flagship Clinic in Winter Park, Reports Strong Operational Momentum in Q1 2026 and Provides Optimistic Outlook for Remainder of the Year

Wed, 22 Apr 2026 08:00:00 -0400

Winter Park, Florida--(Newsfile Corp. - April 22, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and biologic products through its Adia Med clinics and Adia Labs division, today announced that it is actively looking to acquire a larger property to expand its flagship Adia Med clinic in Winter Park, Florida. This strategic initiative aims to significantly increase the clinic's size and capacity, enabling expanded patient access to advanced...

HEALWELL AI Appoints Brad Porter to Board of Directors

Wed, 22 Apr 2026 03:15:00 -0400

HEALWELL appoints Brad Porter, Chief Commercial Officer of HEALWELL and CEO of Orion Health, to its Board of Directors to strengthen the Company's commercial and strategic expertise.Ian McCrae is stepping down from the Board of Directors to focus on other ventures following the successful integration of Orion Health into HEALWELL.Toronto, Ontario--(Newsfile Corp. - April 22, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence...

TelyRx Announces Year-End 2025 Financial Results

Tue, 21 Apr 2026 16:49:00 -0400

Clearwater, Florida--(Newsfile Corp. - April 21, 2026) - TelyRx Holdings Inc. (TSX: TELY) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today filed audited financial statements for TelyRx, Inc., its wholly-owned subsidiary and reverse takeover acquirer, on SEDAR+ for the year ended December 31, 2025. All dollar amounts are expressed in U.S. dollars.Highlights for the Year and Fourth Quarter of 2025Revenue increased to $42.9...

WELL Health Reports Record Canadian Patient Visits and Primary Care Margin Expansion in Q1-2026

Tue, 21 Apr 2026 07:00:00 -0400

WELL Canada delivered a record ~1.27 million patient visits(1) in Q1-2026, representing 33% year-over-year growth and 13% organic growth, reflecting broad-based strength across its national network.Primary Care Adjusted EBITDA(2) margins expanded to approximately 8% in Q1-2026 on a preliminary basis, up approximately 200 basis points from 6% in Q1-2025, driven by WELL's clinic transformation program and recent accretive acquisitions. Specialty Care margins continued to comfortably exceed...

LevelJump Closes Non-Brokered Private Placement

Mon, 20 Apr 2026 12:12:00 -0400

Toronto, Ontario--(Newsfile Corp. - April 20, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce that, further to its news release of April 7, 2026, it has closed, effective as of April 16, 2026, a non-brokered private placement (the "Offering") through the issuance of 14,380,000 common shares (the "Offered Shares") at a price of C$0.05 per Offered Share in the capital of the Company for gross proceeds of C$719,000.All securities issued and...